Register for the Pelvic Mesh Class Action
Transvaginal mesh implants have caused widespread and irreparable damage to quality of life of hundreds of Australian women across the country, as confirmed in the report by Senate Community Affairs References Committee handed down on Wednesday 28 March 2018.
This risk of complication does not appear to be isolated to any one particular manufacturer of pelvic mesh, but rather attached to the product itself.
We are therefore encouraging any woman who has had a pelvic mesh implant and suffered complications following their surgery to contact us as we continue to investigate whether that risk of complication was properly known and disclosed before they agreed to proceed with the surgery.
Do I have a pelvic mesh implant?
There have been a number of medical devices on the market for use in the surgical treatment of stress urinary incontinence and pelvic organ prolapse in women. They are referred to by different names, including tape, sling or mesh, depending on their purpose.
Our investigation focuses only on those women who have had mesh implanted to treat pelvic organ prolapse and who are not already part of a class action.
Pelvic organ prolapse (POP) occurs when the internal tissues and muscles are stretched or damaged, causing the pelvic organs (meaning one or more of the bladder, uterus and rectum) to bulge or sag down into the vagina.
This damage is usually caused by long term coughing or strain, obesity, pregnancy or childbirth and menopause. About 50 per cent of women who have gone through childbirth will experience some degree of prolapse in their lifetimes.
Pelvic mesh is a synthetic mesh (generally a non-absorbable polypropylene) surgical implant used to repair the weakened tissue of the affected pelvic organ.
At this stage, we are not investigating women who have been implanted with mid-urethral slings to treat stress urinary incontinence (the involuntary leakage of urine with activity).
Was the risk of complication unacceptable?
Pelvic mesh was introduced onto the market in the late 1990s as a superior procedure for correcting pelvic organ prolapse on the basis that it offered women a quicker recovery and reduced the risk of recurrence of prolapse.
However, a significant number of women have instead experienced irreparable damage as a result of these pelvic mesh implants. The most common complications arising from pelvic mesh are chronic vaginal pain and mesh exposure, which in many instances have required further surgery to correct.
Slater and Gordon is investigating whether pelvic mesh implants should ever have been sold on the market without greater knowledge of the associated risks.
This includes examining whether manufacturers had enough supporting clinical evidence to ensure the products were safe and effective before releasing them on the market.
Who is affected?
Any woman who has experienced complications following a pelvic mesh implant in Australia and is not already seeking compensation could potentially be included in a further class action.
The common physical and emotional complications associated with pelvic mesh implants include:
Mesh extrusion, erosion or exposure into the vagina or other organs;
Acute and/or chronic vaginal pain;
Pain during intercourse;
Urinary and incontinence problems;
Constipation or defecation dysfunction;
Anxiety and depression.
Manufacturers we are investigating include:
Register your interest for the pelvic mesh class action
Submit your details below for more information about these potential class actions or to register your interest.
We understand the sensitive nature of these claims and can assure that any information supplied will be treated with utmost confidence.
Senate Community Affairs References Committee, Parliament of Australia, Number of women in Australia who have had transvaginal mesh implants and related matters (2018).
Australian Government Department of Health, Submission No 19 to Senate Community Affairs References Committee, Parliament of Australia, Inquiry into the Number of women in Australia who have had transvaginal mesh implants and related matters, 31 May 2017, 18.